Risks, Benefits Need Continual Analysis
Special to Roll Call
It seems like every day there is a new crisis about the Food and Drug Administration or one of the products it regulates. One of the latest incidents, contamination of toothpaste and cough medicine with diethylene glycol, ironically centered on the very same chemical contaminating medicines that led to the creation of the Food, Drug and Cosmetic Act, and the FDA as we know it, in 1938. As we come full circle, it is becoming increasingly clear that we need to give the FDA more tools to evaluate and monitor the safety and effectiveness of drugs.
Forget your password? Click here or
Call 202-824-6800
Subscribe to Print and/or Online
Click Here
Hill Users have Free access,
click Here to register.
Schumer Advocates for Many on Panel
Nov. 16, 12 a.m.
As Senate Majority Leader, Lyndon Johnson once said of the Joint Economic Committee, “It’s as useless as tits on a bull.” But as that panel’s chairman during the 110th Congress, Sen. Charles Schumer (D-N.Y.) seized the opportunity to elevate the traditionally low-profile post to the forefront of shaping policy. Read Full Article
Roll Call Video Channels
